ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 76 filers reported holding ORCHARD THERAPEUTICS PLC in Q3 2020. The put-call ratio across all filers is 4.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $31,000 | -91.4% | 23,547 | -85.0% | 0.00% | -100.0% |
| Q3 2021 | $361,000 | -9.5% | 157,194 | +136.7% | 0.00% | -66.7% |
| Q2 2020 | $399,000 | -79.1% | 66,423 | -52.2% | 0.00% | -76.9% |
| Q4 2019 | $1,909,000 | +471.6% | 138,830 | +393.7% | 0.01% | +333.3% |
| Q3 2019 | $334,000 | -5.1% | 28,123 | +11.7% | 0.00% | 0.0% |
| Q2 2019 | $352,000 | – | 25,177 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 4,081,972 | $9,388,000 | 2.74% |
| RA Capital Management | 11,028,722 | $25,366,000 | 0.35% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,949,416 | $15,984,000 | 0.31% |
| Avidity Partners Management LP | 3,836,798 | $8,825,000 | 0.20% |
| Casdin Capital, LLC | 2,575,000 | $5,923,000 | 0.15% |
| Vivo Capital, LLC | 1,325,736 | $3,049,000 | 0.14% |
| Artal Group S.A. | 1,803,858 | $4,149,000 | 0.09% |
| Eversept Partners, LP | 569,581 | $1,310,036 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 374,811 | $862,000 | 0.09% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,078,315 | $2,480,000 | 0.07% |